Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month MONT BLANC study results

Research output: Contribution to journalJournal articleResearchpeer-review

  • Larsen, Michael
  • Ursula Schmidt-Erfurth
  • Paolo Lanzetta
  • Sebastian Wolf
  • Christian Simader
  • Erika Tokaji
  • Stefan Pilz
  • Annemarie Weisberger
  • MONT BLANC Study Group
To compare the efficacy and safety of same-day verteporfin photodynamic therapy (PDT) and intravitreal ranibizumab combination treatment versus ranibizumab monotherapy in neovascular age-related macular degeneration.
Original languageEnglish
JournalOphthalmology
Volume119
Issue number5
Pages (from-to)992-1000
Number of pages9
ISSN0161-6420
DOIs
Publication statusPublished - 2012

ID: 48509739